Clinical Trial: Perichondrium Autograft in Refractory Necrotizing Scleritis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Autologous Perichondrium Transplantation for Replacement of Stem Cells and Their Niche in the Treatment of Necrotizing Scleritis

Brief Summary:

Necrotizing scleritis with severe ischemia is refractory to conventional treatment because of avascular necrosis.

The investigators assessed the therapeutic efficacy and safety of autologous perichondrium transplantation in patients with severe ischemic necrotizing scleritis, and analyzed the therapeutic effects.